Please assess the completion status of the following clinical trial:

Trial Title: HeartPhone Cancer Survivors Trial 2019

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-65 years~* Diagnosis of breast cancer, leukemia, or lymphoma \<15 yrs~* Completed chemotherapy with cardiotoxic anthracycline-based agents 1+ year ago~* English-proficiency~* Own \& use smartphone with Android operating system~Main Study and Ancillary Study Exclusion Criteria:~* Currently receiving curative treatment for cancer~* 90+ min/week moderate (or greater) intensity PA~* Any medical contraindications on the Physical Activity Readiness Questionnaire~* Require an assistive device for mobility or has any other condition that may limit or prevent participation in moderate-intensity physical activity~* Current smoker~* Pregnant or planning to become pregnant in the next 6 mos/breastfeeding~* Allergy to test substances~* Allergy to latex~Ancillary Study:~* Taking metformin~* Current medications that could conceivably alter the cardiovascular or thermoregulatory control or responses (e.g. beta blockers, calcium channel blockers, angiotensin receptor blockers)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- HeartPhone Intervention (Type: EXPERIMENTAL): Participants install the HeartPhone app on their smartphone. This app presents an image on a splash screen every time they activate their device. The image is randomly drawn from an image bank in the app. Repeated exposure to the image is designed to condition a more favorable automatic affective evaluation of physical activity and lead to increased physical activity.

Based on this trial design, predict the completion outcome and termination type (if applicable).